The capacity of MACC1 to upregulate c-MET expression transcriptionally has been shown in CRC, ovarian cancer (OC), pancreatic cancer (PDAC) and osteosarcoma [4, 81–83]. Here, MACC1 is linked to colorectal carcinoma.